Changes / RenewalRSSAbout RSS
- November 29, 2019 Release JT Files New Drug Application of Enarodustat (JTZ-951), for the Treatment of Anemia Associated with CKD in Japan（PDF）
- November 25, 2019 Release Transfer of rights to uricosuric agent URINORM®（PDF）
- November 5, 2019 Release Torii has entered into a License Agreement with BioCryst Pharmaceuticals, Inc. for BCX7353 for the prevention of HAE attacks（PDF）
- October 31, 2019 Information " Financial Results " was updated.
- September 2, 2019 Release JT Transfers the Marketing Approvals of Six Anti-HIV Drugs in Japan to Gilead Sciences K.K.（PDF）